Market Cap

Vyant Bio, Inc. Market Capitalization:

$1.2 Million

USD as of Dec. 1, 2023

business Vyant Bio, Inc. Company Profile

Vyant Bio, Inc. Main Stock Listing

NASDAQ: VYNT

Market Capitalization History of Vyant Bio, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Vyant Bio, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $4.8 M -19.61%
Jan. 1, 2022 $6.0 M -74.50%
Jan. 1, 2021 $23.5 M -4.76%
Jan. 1, 2020 $24.7 M -41.67%
Jan. 1, 2019 $42.3 M -88.00%
Jan. 1, 2018 $352.5 M -6.98%
Jan. 1, 2017 $378.9 M -17.62%
Jan. 1, 2016 $460.0 M -65.61%
Jan. 1, 2015 $1.34 B -57.22%
Jan. 1, 2014 $3.13 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Vyant Bio, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Vyant Bio, Inc. has the following listings and related stock indices.


Stock: NASDAQ: VYNT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.